Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Aldeyra Therapeutics, Inc. | Financial_Report.xls |
| 10-K - FORM 10-K - Aldeyra Therapeutics, Inc. | d851682d10k.htm |
| EX-31.2 - EX-31.2 - Aldeyra Therapeutics, Inc. | d851682dex312.htm |
| EX-31.1 - EX-31.1 - Aldeyra Therapeutics, Inc. | d851682dex311.htm |
| EX-32.1 - EX-32.1 - Aldeyra Therapeutics, Inc. | d851682dex321.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Aldeyra Therapeutics, Inc.
Lexington, Massachusetts
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-196674) of Aldeyra Therapeutics, Inc. of our report dated March 23, 2015, relating to the financial statements of Aldeyra Therapeutics, Inc., appearing in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014.
/s/ BDO USA, LLP
Boston, Massachusetts
March 23, 2015